Overview

Laurel Biotherapeutics is building a new class of precision biologics at the intersection of cardiovascular disease and serious comorbid conditions affecting millions of patients. At Laurel, we focus on restoring protective biological signaling pathways that regulate cardiac and systemic health. Our initial program in cardiorenal disease leverages targeted nanobody therapeutics to activate the natriuretic peptide pathway, representing the first step in our broader platform strategy to redefine cardiovascular treatment.